A New Pathway In Psoriatic Arthritis: Dr. Eric Ruderman

A New Pathway in Psoriatic Arthritis: Dr. Eric Ruderman

Axial Involvement in Psoriatic Arthritis: Perspective by Dr. Eric Ruderman

RNL 2021 - Advancing Treatment in Psoriatic Arthritis - Dr. Eric Ruderman

Dr. Eric Ruderman on New Mechanisms of Action on Psoriatic Arthritis

Psoriatic Arthritis: What's with Brepocitinib? Dr. Eric Ruderman

Shifting Treatment Paradigms in Psoriatic Arthritis: Dr. Eric Ruderman

Pediatric Psoriatic Arthritis: Dr. Eric Ruderman

Measuring Disease Activity in Psoriatic Arthritis: Dr. Eric Ruderman

Psoriatic Arthritis and Guselkumab: Dr. Eric Ruderman

Psoriatic Arthritis Guidelines (updated)

CBD and Opioids in Psoriatic Arthritis: Dr. Eric Ruderman

Psoriatic Arthritis Topic Panel: EULAR 2024

TNR: Modern Management of Psoriatic Arthritis

PsA Perspectives - IL-23: Dr. Eric Ruderman

Psoriatic Arthritis Panel Discussion

A Psoriatic Arthritis Research Update

National Psoriasis Foundation

Mid-Meeting Recap: Psoriatic Arthritis

Eric M. Ruderman, MD

Northwestern Medicine

RheumNow Live Preview with Dr. Eric Ruderman

S2-Ep.3 I Dr. Ruderman’s Insights: Collaborative Care & Individualized Management Strategies for PsA